Calendar

Jul
31
Wed
2019
MIPS Seminar: Dr. Umar Mahmood
Jul 31 @ 1:00 pm – 2:30 pm
MIPS Seminar: Dr. Umar Mahmood

1:00pm-2:00pm: Presentation and Q&A
2:00pm-2:30pm: Light Refreshments

Talk title: Precision Imaging Guides Cancer Therapy

Historically, many of the gains in medicine have been achieved by uniformly applying medical insights to large groups of patients. A combination of increasing biological understanding of the heterogeneity of disease processes and the concurrent expansion of available selective therapeutic interventions has provided the opportunity to improve group outcomes by optimizing treatment on an individual basis. In many cases, molecular imaging is ideally suited to serve as a biomarker to guide therapy selection and dosing, and to provide an early assessment of efficacy. This presentation highlights by example several areas in which imaging helps determine target engagement, dynamic cellular response to treatment, and the effectiveness of immune modulation in oncologic treatment.

Nov
20
Wed
2019
IBIIS & AIMI Seminar – Okyaz Eminaga, MD, PhD @ Clark Center - S360
Nov 20 @ 12:00 pm – 1:00 pm
IBIIS & AIMI Seminar - Okyaz Eminaga, MD, PhD @ Clark Center - S360

Integrative Biomedical Imaging Informatics at Stanford (IBIIS) and Center for Artificial Intelligence in Medicine & Imaging (AIMI) Seminar: “AI-Aided Diagnostic and Prognostic Tools for Prostate Cancer”

Okyaz Eminaga, MD, PhD
Postdoctoral Research Fellow, Urology
Biomedical Data Sciences
Stanford University

James H. Clark Center, S360
12:00pm-1:00pm – Seminar and Discussion (light refreshments provided)
Join via Zoom: https://stanford.zoom.us/j/613898274

ABSTRACT: Prostate Cancer exhibits different clinical behavior, ranging from indolent to lethal disease. A critical clinical need is identifying characteristics that distinguish indolent from advanced disease to direct treatment to the latter. The recent renaissance of artificial intelligence (AI) research uncovered the potential of AI to improve clinical decision making. In this seminar, we will go through the potential of AI to enhance the diagnosis and the prognosis of prostate cancer using magnetic resonance images, clinical data, and histology images. We will stress the challenges and benefits of having such AI-based solutions in clinical routine.

ABOUT: Dr. Eminaga passed his medical examination (Staatsexamen) 2009 and received his Ph.D. in Medicine 2010 from University of Muenster (major topic: medical informatics) under the supervision of Professor Dr. Axel Semjonow (one of the pioneer physician-scientists and biomarker researcher who worked on the standardization of PSA measurement for prostate cancer which is used nowadays) and Professor Dr. Martin Dugas (who is the head of European Research Center for Information Systems and one of the most influential professors in medical informatics in Europe). For those who don’t know the institute of medical informatics in Muenster. The systematized Nomenclature of Human and Veterinary Medicine (SNOMED), which is now used worldwide in medical information systems, was initiated by this institute more than 30 years ago.

His doctoral dissertation presented a novel documentation architecture for clinical data and imaging called cMDX (clinical map document) that facilitates the concept of the single-source information system for clinical data storage and analysis, and is successfully used in clinical routine for generating the pathology reports with graphical information about the spatial tumor extent for prostatectomy specimens since 2009 at the prostate center of University Hospital Muenster. This work has been also utilized for more than 20 studies related to genomics, translational medicine, epidemiology, urology, radiology, and pathology. Dr. Eminaga also established the biobanking information management system to manage the samples of one of the largest biobanks for prostate cancer in Europe. This biobank is also part of the European P-Mark network for prostate cancer-related biorepositories initiated by Oxford University.

Dr. Eminaga completed his residency in Urology in the University Hospital of Cologne (Germany) with a major focus on uro-oncology. He was also a research fellow in Prostate Center of University Hospital Muenster, doing research in biomarkers, biobanking infrastructure, epidemiology and histopathology. During his residency fellowship, he further evaluated the role of certain miRNA in prostate cancer development under the supervision of the molecular biologist Dr. Warnecke-Eberz. After his residency, he started a research scholarship at the laboratory of Dr. Brooks, doing genomic research and bioinformatics for research topics related to prostate cancer evolution. Now, his current interests have expanded to statistical learning, medical imaging informatics, and integrative data analysis.

He is the recipient of 3 highly-competitive scholarships and his works have been recognized at national and international levels e.g., by the European Association of Urology. Currently, he is an early-investigator research awardee for prostate cancer managed by the department of defense and works on developing decision-aided tools for diagnosis and prognosis of prostate cancer.

Follow us on Twitter: @StanfordIBIIS and @StanfordAIMI
http://ibiis.stanford.edu/events/seminars/2019seminars.html

Dec
11
Wed
2019
AIMI, IBIIS & RSL Special Seminar – John Stafford & Bjorn Carey @ Clark Center - S360
Dec 11 @ 10:00 am – 11:00 am
AIMI, IBIIS & RSL Special Seminar - John Stafford & Bjorn Carey @ Clark Center - S360

“Messaging in the Age of Microtargeting”

John Stafford
Assistant Vice President
Digital Strategy
Stanford University

Bjorn Carey
Senior Director
Digital Strategy
Stanford University

Join via Zoom: https://stanford.zoom.us/j/400566542

Abstract:
Communications has become increasingly data-driven, targeted, and personalized. This has changed how Stanford analyzes communications opportunities from a research perspective and how it engages with relevant audiences. In this presentation, John and Bjorn will share the data and communications strategy underlying three communications initiatives and the resulting execution. They will also provide practical advice for individual thought leadership and communications in this dynamic environment.

About:
John Stafford, MA ’06, is currently Assistant Vice President for Digital Strategy at Stanford, the most senior digital communications role in the university. John is responsible for all aspects of creating a world-class digital communications function: setting the group’s strategy, building analytics and insight programs, counseling on crisis communications, leading multi-channel messaging initiatives, and advising colleagues across the University. He received a Master’s Degree in Communication from Stanford, a B.A. in History from the University of San Francisco, and was a founding advisor to Stanford Medicine X.

Refreshments will be provided.

AIMI & IBIIS Seminar – Luciano M. Prevedello, MD, MPH @ Clark Center - S360
Dec 11 @ 2:00 pm – 3:00 pm
AIMI & IBIIS Seminar - Luciano M. Prevedello, MD, MPH @ Clark Center - S360

“Algorithm Development Lifecycle in Medical Imaging:
Current State and Considerations for the Future”

Luciano M. Prevedello, MD, MPH
Vice-Chair for Medical Informatics and Augmented Intelligence in Imaging
Division Chief, Medical Imaging Informatics
Director, 3D and Advanced Visualization Lab
Associate Professor, Division of Neuroradiology,
Department of Radiology
Ohio State University Wexner Medical Center

Join via Zoom: https://stanford.zoom.us/j/267814863

Abstract:
This presentation will describe some of the most important considerations involved in creating algorithms in medical imaging from inception to deployment as well as continued model improvement and/or monitoring. Examples of experience to date from the OSU laboratory for augmented intelligence in imaging will be provided. New paradigms in model creation and the role of image challenge competitions will also be covered. Current issues with model validation and generalizability will also be introduced as well as considerations for future work in this area.

Refreshments will be provided.

Jan
15
Wed
2020
AIMI & IBIIS Seminar – Wei Shao, PhD & Saeed Seyyedi, PhD @ Clark Center - S360
Jan 15 @ 12:00 pm – 1:00 pm
AIMI & IBIIS Seminar - Wei Shao, PhD & Saeed Seyyedi, PhD @ Clark Center - S360

“A Deep Learning Framework for Efficient Registration of MRI and Histopathology Images of the Prostate”

Wei Shao, PhD
Postdoctoral Research Fellow
Department of Radiology
Stanford University

“Applications of Generative Adversarial Networks (GANs) in Medical Imaging”

Saeed Seyyedi, PhD
Paustenbach Research Fellow
Department of Radiology
Stanford University

Join via Zoom: https://stanford.zoom.us/j/593016899

Refreshments will be provided

ABSTRACT (Shao)
Magnetic resonance imaging (MRI) is an increasingly important tool for the diagnosis and treatment of prostate cancer. However, MRI interpretation suffers from high interobserver variability and often misses clinically significant cancers. Registration of histopathology images from patients who have undergone surgical resection of the prostate onto pre-operative MRI images allows direct mapping of cancer location onto MR images. This is essential for the discovery and validation of novel prostate cancer signatures on MRI. Traditional registration approaches can be computationally expensive and require a careful choice of registration hyperparameters. We present a deep learning-based pipeline to accelerate and simplify MRI-histopathology image registration in prostate cancer. Our pipeline consists of preprocessing, transform estimation by deep neural networks, and postprocessing. We refined the registration neural networks, originally trained with 19,642 natural images, by adding 17,821 medical images of the prostate to the training set. The pipeline was evaluated using 99 prostate cancer patients. The addition of the images to the training set significantly (p < 0.001) improved the Dice coefficient and reduced the Hausdorff distance. Our pipeline also achieved comparable accuracy to an existing state-of-the-art algorithm while reducing the computation time from 4.4 minutes to less than 2 seconds.

ABSTRACT (Seyyedi)
Generative adversarial networks (GANs) are advanced types of neural networks where two networks are trained simultaneously to perform two tasks of generation and discrimination. GANs have gained a lot of attention to tackle well known and challenging problems in computer vision applications including medical image analysis tasks such as medical image de-noising, detection and classification, segmentation and reconstruction.In this talk, we will introduce some of the recent advancements of GANs in medical imaging applications and will discuss the recent developments of GAN models to resolve real world imaging challenges.

Feb
3
Mon
2020
MIPS Seminar – Agata A. Exner, Ph.D. @ Beckman Center, B230
Feb 3 @ 2:00 pm – 3:00 pm
MIPS Seminar - Agata A. Exner, Ph.D. @ Beckman Center, B230

MIPS Seminar: “Tiny Bubbles, Big Impact: Exploring applications of nanobubbles in ultrasound molecular imaging and therapy”

Agata A. Exner, Ph.D.
Professor of Radiology and Biomedical Engineering

Department of Radiology

Case Western Reserve

Location: Beckman Center, B230
2:00pm – 3:00pm Seminar & Discussion

ABSTRACT
Sub-micron shell stabilized gas bubbles (aka nanobubbles (NB) or ultrafine bubbles) have gained momentum as a robust contrast agent for molecular imaging and therapy using ultrasound. The small size, extended stability and high concentration of nanobubbles make them an ideal tool for new applications of contrast enhanced ultrasound and ultra-
sound-mediated therapy, especially in oncology-related problems. Compared to microbub-bles, nanobubbles can provide superior tumor delineation, identify biomarkers on the vascu-lature and on tumors cells and facilitate drug and gene delivery into tumor tissue. The pat-terns of tissue enhancement under nonlinear ultrasound imaging of nanobubbles are distinct from conventional microbubbles especially in tissues exhibiting vascular hyperper-meability. Specifically, NB kinetics, quantified via time intensity curve analysis, typically show a marked delay in the washout rate and significantly increased area under the curve compared to larger bubbles. This effect is further enhanced by molecular targeting to cellular biomarkers, such as the prostate specific membrane antigen (PSMA) or the receptor protein tyrosine phosphatase, PTPmu. The unique contrast enhancement dynamics of nanobubbles are likely to be a result of direct bubble extravasation and prolonged retention of intact bubbles in target tissue. Thus, understanding the underlying mechanisms behind the unique nanobubble behavior can be the driver of significant future innovations in contrast enhanced ultrasound imaging applications. This presentation will discuss the fundamental challenges with nanobubble formulation and characterization and will showcase how the unique fea-tures of nanobubbles can be leveraged to improve disease detection and treatment using ultrasound.

 

Feb
13
Thu
2020
Evolving Health Care from an Artisanal Organization into an Industrial Enterprise @ Clark Center, S361
Feb 13 @ 12:30 pm – 1:30 pm
Evolving Health Care from an Artisanal Organization into an Industrial Enterprise @ Clark Center, S361

Ron Kikinis, MD
Director of the Surgical Planning Laboratory
Professor of Radiology
Department of Radiology
Brigham and Women’s Hospital
Harvard Medical School

Title: Evolving Health Care from an Artisanal Organization into an Industrial Enterprise

Refreshments will be provided

Join via Zoom: https://stanford.zoom.us/j/996417088

Abstract: During the last decade, results from basic research in the fields of genetics and immunology have begun to impact treatment in a variety of diseases. Checkpoint therapy, for instance has fundamentally changed the treatment and survival of some patients with melanoma. The medical workplace has transformed from an artisanal organization into an industrial enterprise environment. Workflows in the clinic are increasingly standardized. Their timing and execution are monitored through omnipresent software systems. This has resulted in an acceleration of the pace of care delivery. Imaging and image post-processing have rapidly evolved as well, enabled by ever-increasing computational power, novel sensor systems and novel mathematical approaches. Organizing the data and making it findable and accessible is an ongoing challenge and is investigated through a variety of research efforts. These topics will be reviewed and discussed during the lecture.

About:

Dr. Kikinis is the founding Director of the Surgical Planning Laboratory, Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, and a Professor of Radiology at Harvard Medical School. This laboratory was founded in 1990. Before joining Brigham & Women’s Hospital in 1988, he trained as a resident in radiology at the University Hospital in Zurich, and as a researcher in computer vision at the ETH in Zurich, Switzerland. He received his M.D. degree from the University of Zurich, Switzerland, in 1982. In 2004 he was appointed Professor of Radiology at Harvard Medical School. In 2009 he was the inaugural recipient of the MICCAI Society “Enduring Impact Award”. On February 24, 2010 he was appointed the Robert Greenes Distinguished Director of Biomedical Informatics in the Department of Radiology at Brigham and Women’s Hospital. On January 1, 2014, he was appointed “Institutsleiter” of Fraunhofer MEVIS and Professor of Medical Image Computing at the University of Bremen. Since then he is commuting every two months between Bremen and Boston.

During the mid-80’s, Dr. Kikinis developed a scientific interest in image processing algorithms and their use for extracting relevant information from medical imaging data. Due to the explosive increase of both the quantity and complexity of imaging data this area of research is of ever-increasing importance. Dr. Kikinis has led and has participated in research in different areas of science. His activities include technological research (segmentation, registration, visualization, high performance computing), software system development, and biomedical research in a variety of biomedical specialties. The majority of his research is interdisciplinary in nature and is conducted by multidisciplinary teams. The results of his research have been reported in a variety of peer-reviewed journal articles. He is an author and co-author of over 350 peer-reviewed articles.

Follow us on Twitter: @StanfordIBIIS

http://ibiis.stanford.edu/events/seminars/2020seminars.html

MIPS Seminar – Prof. Pawel Moskal & Prof. Ewa Stepien @ James H. Clark Center, S360
Feb 13 @ 2:00 pm – 3:30 pm
MIPS Seminar - Prof. Pawel Moskal & Prof. Ewa Stepien @ James H. Clark Center, S360

MIPS Seminar

2:00-2:45 PM | Prof. Pawel Moskal

“Positronium Imaging with the J-PET Scanner”

Head of  the Department of Experimental Particle Physics and Applications
Marian Smoluchowski Institute of Physics
Jagiellonian University, 30-348 Krakow, Poland

2:45-3:30 PM | Prof. Ewa Stepien

“Preclinical studies of positronium and extracellular vesicles biomarkers”

Head of the Department of Medical Physics
Marian Smoluchowski Institute of Physics
Jagiellonian University, 30-348 Krakow, Poland

 

ABSTRACT

As modern medicine develops towards personalized treatment of patients, there is a need for highly specific and sensitive tests to diagnose disease. Our research aims at improvement of specificity of positron emission tomography (PET) in assessment of cancer by use of positronium as a theranostic agent. During PET scanning about 40% of positron annihilations occur through the creation of positronium. “Positronium,” which may be formed in human tissues in the intramolecular spaces, is an exotic atom composed of an electron from tissue and the positron emitted by the radioinuclide.  Positronium decay in the patient body is sensitive to the nanostructure and metabolism of human tissues. This phenomenon is not used in present PET diagnostics, yet it is in principle possible to exploit such environment modified properties of positronium as diagnostic biomarkers for cancer assessment. Our first in-vitro studies have shown differences of the positronium mean lifetime and production probability in healthy and cancerous tissues, indicating that they may be used as indicators for in-vivo cancer classification. For the application in medical diagnostics, the properties of positronium atoms need to be determined in a spatially resolved manner. For that purpose we have developed a method of positronium lifetime imaging in which the lifetime and position of positronium atoms are determined on an event-by-event basis. This method requires application of β+ decaying isotope that also emits a prompt gamma ray. We will argue that with total-body PET scanners, the sensitivity of positronium lifetime imaging, which requires coincident registration of the back-to-back annihilation photons and the prompt gamma, is comparable to the sensitivities for metabolic imaging with standard PET scanners.

Our research involves also development of diagnostic methods based on the extracellular vesicles (EVs), which are micro and nano-sized, closed membrane fragments. They are produced by native cells to facilitate the transfer of different signaling factors, structural proteins, nucleic acids or lipids even to distant cells. They are present in all body fluids and they are specific to their parental cells.

Our presentation will be divided into two parts. In the first, the method of positronium imaging and the pilot positronium images obtained with the J-PET detector (the first PET system built based on plastic scintillators) will be reported. This part of the presentation will include also description and perspectives of development of the J-PET technology in view of total-body PET imaging. The second part will concern preliminary results of the preclinical studies of positronium properties in cancerous and healthy tissues sampled from patients as well as in the frozen and living healthy and cancer skin cells in-vitro. The second part will include also description of the novel method for the diagnosis of diabetes and melanoma based on EVs used as biomarkers and drug delivery systems.

References:
P. Moskal, …. E. Ł. Stępień et al., Phys. Med. Biol. 64 (2019) 055017

  1. Moskal, B. Jasinska, E. Ł. Stępień, S. Bass, Nature Reviews Physics 1 (2019) 527
  2. Roman M… .E. Ł. Stępień, Nanomedicine 17 (2019) 137
  3. Ł. Stępień et al., Theranostics 8 (2018) 3874

 

Hosted by: Craig Levin, Ph.D.
Sponsored by the Molecular Imaging Program at Stanford and the Department of Radiology

Feb
19
Wed
2020
Deploying AI in the Clinical Radiology Workflow: Challenges, Opportunities, and Examples @ Clark Center S360
Feb 19 @ 2:00 pm – 3:00 pm
Deploying AI in the Clinical Radiology Workflow: Challenges, Opportunities, and Examples @ Clark Center S360

Tessa Cook, MD, PhD
Assistant Professor of Radiology
Perelman School of Medicine
University of Pennsylvania

Title: Deploying AI in the Clinical Radiology Workflow: Challenges, Opportunities, and Examples

Abstract: Although many radiology AI efforts are focused on pixel-based tasks, there is great potential for AI to impact radiology care delivery and workflow when applied to reports, EMR data, and workflow data. Radiology-pathology correlation, identification of follow-up recommendations, and report segmentation can be used to increase meaningful feedback to radiologists as well as to automate tasks that are currently manual and time-consuming. When deploying AI within the clinical workflow, there are many challenges that may slow down or otherwise affect the integration. Careful consideration of the way in which radiologists may expect to interact with AI results should be undertaken to meaningfully deploy radiology AI in a safe and effective way.

Mar
6
Fri
2020
CANCELLED – MIPS Seminar – Pritha Ray, Ph.D. @ James H. Clark Center, S360
Mar 6 @ 11:00 am – 12:00 pm
CANCELLED - MIPS Seminar - Pritha Ray, Ph.D. @ James H. Clark Center, S360

Please note this seminar is now cancelled and will be rescheduled for a later date. 

MIPS Seminar: Investigating and Imaging key molecular switches associated with Acquirement of Platinum-Taxol resistance in Epithelial Ovarian Cancer

Pritha Ray, Ph.D.

Principal Investigator & Scientific Officer F
Imaging Cell Signaling & Therapeutics Lab
ACTREC, Tata Memorial Center
Navi Mumbai, India